Department of Neurosurgery, NYU Langone Health, New York, New York, USA.
Department of Neurology, Booth Gardner Parkinson's Care Center, EvergreenHealth, Kirkland, Washington.
Oper Neurosurg (Hagerstown). 2024 Sep 1;27(3):295-302. doi: 10.1227/ons.0000000000001142. Epub 2024 Apr 9.
Despite the well-established efficacy of deep brain stimulation (DBS) of the subthalamic nucleus (STN) for Parkinson's Disease (PD), there remains a subset of patients with only a moderate improvement in symptoms even with appropriate lead placement and optimal programming. In patients with persistent tremor or dyskinesias, one consideration is the addition of a second "rescue lead" to provide dual stimulation to primary and secondary targets to address the refractory component. This study aimed to assess all "rescue lead" cases from our institution and characterize the patients and their outcomes.
Records of all patients with PD treated at our institution between 2005 and 2023 were retrospectively reviewed. Clinical data of all patients treated with a second rescue lead to supplement a positive but inadequate initial DBS response were collected and reviewed.
Of 670 patients with PD treated at our institution during the study period, 7 were managed with a rescue lead. All 7 were initially treated with STN DBS with a partial improvement in underlying symptoms, had confirmed appropriate lead placement, and underwent thorough programming. Four patients underwent rescue with a globus pallidus interna lead for persistent dyskinesias, all with subsequent improvement in their dyskinesias. Three patients had persistent tremors that were treated with a rescue ventrointermediate thalamus stimulation with subsequent improvement in tremor scores. There were no operative complications, and all patients tolerated dual stimulation.
For a small subset of patients with PD with persistent dyskinesias or tremors after STN DBS despite optimized lead parameters and adequate lead placement, rescue lead placement offers an effective treatment option.
尽管深部脑刺激(DBS)对丘脑底核(STN)治疗帕金森病(PD)的疗效已得到充分证实,但仍有一部分患者即使进行了适当的导联放置和最佳的程控,其症状也仅有中度改善。对于持续震颤或运动障碍的患者,一种考虑是增加第二个“救援导联”,以提供对主要和次要目标的双重刺激,以解决难治性成分。本研究旨在评估我们机构所有的“救援导联”病例,并对患者及其结局进行特征描述。
回顾性分析了我们机构 2005 年至 2023 年间治疗的所有 PD 患者的记录。收集并回顾了所有接受第二个救援导联治疗以补充初始 DBS 反应不足的患者的临床数据。
在研究期间,我们机构共治疗了 670 例 PD 患者,其中 7 例采用救援导联治疗。这 7 例患者最初均接受 STN-DBS 治疗,症状有所改善,但仍存在部分症状,且确认了适当的导联放置,并进行了全面程控。4 例因持续性运动障碍而采用苍白球内导联进行救援治疗,所有患者的运动障碍均有改善。3 例患者持续性震颤,采用丘脑腹中间核刺激进行救援治疗,震颤评分均有所改善。无手术并发症,所有患者均耐受双重刺激。
对于 STN-DBS 后持续存在运动障碍或震颤且优化了导联参数和适当的导联放置后仍无法缓解的一小部分 PD 患者,救援导联的放置提供了一种有效的治疗选择。